Drug Profile
Teriparatide nasal spray
Alternative Names: CHS-13340; Nasal rhPTH(1-34); Parathyroid hormone (1-34) - Chugai/Suntory; PTH (1-34) - Chugai/Suntory; SUN E 3001Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Asubio Pharma
- Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 09 May 2008 Teriparatide nasal spray is still in phase II development for osteoporosis in Japan
- 20 Mar 2008 Discontinued - Preclinical for Postmenopausal osteoporosis in World (Intranasal)
- 01 Apr 2007 Daiichi Asubio Pharma is now called Asubio Pharma